Imagion Biosystems President and CEO Bob Proulx was interviewed today by Health Professional Radio, a media network dedicated to promoting awareness on healthcare issues. In his interview of Mr. Proulx, Henry Acosta of Health Professional Radio draws out descriptions of the key elements of Imagion Biosystems’ MagSense® cancer detection technology, the company’s commercialization plan, and what motivates Mr. Proulx and the company’s employees, collaborators, and investors to get MagSense® technology into hospitals and medical clinics just as soon as possible.
Listen to the eight-minute audio file here:
Positive Results Received from WSU on MagSense® Dosage – Phase 2 Clinical Trial on HER2 Breast Cancer Imaging Agent
November 5, 2025
FDA Submission of IND for MagSense® HER2 Phase 2 Clinical Trial on Track Q4 2025 Key Highlights: Wayne State University Collaboration Program Delivers Positive and